Masashi Hirayama, Arata Watanabe (Nakadori General Hospital, Akita, Japan)
Session information
Poster Session
Sun.Oct,13
Poster Session 3-13 Emicizumab
Sun. Oct 13, 2019 1:20 PM - 1:55 PM Poster (Tokyo International Forum, B2F Hall E)
Chair: Keiji Nogami (Department of Pediatrics, Nara Medical University)
Yuko Hayashi1,2, Mikiya Endo2, Keisuke Oikawa2, Maya Asami2, Kotaro Oyama2 (1.Iwate Prefectural Ninohe Hospital, Iwate, Japan, 2.Department of Pediatrics, Iwate Medical University)
[PS3-13-3] A good clinical case of perioperative switching from neutralization therapy to emicizumab
Shuichi Okamoto1, Nobuaki Suzuki2, Sachiko Suzuki4, Shogo Tamura4, Mochihito Suzuki5, Nobunori Takahashi5, Toshihisa Kojima5, Naoki Ishiguro5, Takeshi Kanematsu3, Tetsuhito Kojima4, Hitoshi Kiyoi1, Tadashi Matsushita2,3 (1.Hematol and Oncol., Nagoya Univ Grad Sch., Nagoya, Japan, 2.Transfusion Med., Nagoya Univ. Hosp., Nagoya, Japan, 3.Lab. Med., Nagoya Univ. Hosp., Nagoya, Japan, 4.Pathophysiol. Lab. Sci., Nagoya Univ. Grad. Sch., Nagoya, Japan, 5.Orthop. Surg., Nagoya Univ. Sch., Nagoya, japan)
Masamune Higashigawa, Ichiro Kato, Mitsuaki Miyata, Tomohiro Hasegawa, Masaya Nakamura, Sato Nishiyama, Yasuaki Yasuda, Naoki Kamata, Mitsue Ito, Ryoji Ichimi (Department of Pediatrics/Neonatology, Japanese Red Cross Ise Hospital, Ise, Japan)
Mikiya Endo1, Yuko Hayashi2, Hidekazu Maruyama3, Yoshiko Asakura1, Daishi Hirai1, Kotaro Oyama1 (1.Department of Pediatrics Iwate Medical University Morioka Japan, 2.Iwate Prefectual Ninohe Hospital Ninohe Japan, 3.Iwate Perfectual Iwai Hospital Ichinoseki Japan)
Midori Shima1, Takashi Suzuki2, Masashi Taki3, Tadashi Matsushita4, Michio Sakai5, Katsuyuki Fukutake6, Norihiro Okada7, Shingo Maisawa7, Ryu Kasai7, Keiji Nogami1 (1.Department of Pediatrics, Nara Medical University, Kashihara, Japan, 2.Department of Blood Coagulation, Ogikubo Hospital, Tokyo, Japan, 3.Department of Pediatrics, St Marianna University School of Medicine, Kawasaki, Japan, 4.Department of Transfusion Medicine, Nagoya University, Nagoya, Japan, 5.Department of Pediatrics, Munakata Suikokai General Hospital, Fukutsu, Japan, 6.Department of Laboratory Medicine, Tokyo Medical University, Tokyo, Japan, 7.Chugai Pharmaceutical Co., Ltd, Tokyo, Japan)
Yoichi Hamazaki1, Kazuko Akutsu1, Toshiaki Sai1, Daiki Ozawa2, Takayuki Ikezoe3 (1.Department of Hematology, Iwaki City Medical Center, Iwaki, Japan, 2.Department of Otolaryngology, Iwaki City Medical Center, Iwaki, Japan, 3.Department of Hematology, Fukushima Medical University, Fukushima, Japan)